Is there a link between Vitamin B and multiple sclerosis?

Medicinal Chemistry

Volumn 14, Issue 2, 2018, Pages 170-180

  Nemazannikova, Natalie ^a   Mikkelsen, Kathleen ^a   Stojanovska, Lily ^a   Blatch, Gregory L ^a,b   Apostolopoulos, Vasso ^a  

^a VICTORIA UNIVERSITY   (Australia)

^b UNIVERSITY OF NOTRE DAME   (Australia)

Author keywords

Cobalamin; EAE; Folate; Multiple sclerosis; Niacin; Pantothenic acid; Riboflavin; Thiamin; Vitamin B

Indexed keywords

ADENINE; BIOTIN; CYANOCOBALAMIN; FOLIC ACID; NICOTINAMIDE; PANTOTHENIC ACID; PYRIDOXINE; RIBOFLAVIN; THIAMINE; VITAMIN B COMPLEX; VITAMIN B GROUP; ANTIINFLAMMATORY AGENT;

ANTIINFLAMMATORY ACTIVITY; CYANOCOBALAMIN DEFICIENCY; DEMYELINATION; FATIGUE; HUMAN; INFLAMMATION; METHYLATION; MULTIPLE SCLEROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUALITY OF LIFE; REMYELINIZATION; REVIEW; SYMPTOMATOLOGY; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION; CHEMISTRY;

ANTI-INFLAMMATORY AGENTS; HUMANS; MULTIPLE SCLEROSIS; VITAMIN B COMPLEX;

EID: 85042741406     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/1573406413666170906123857     Document Type: Review

References (132)

1. Comi, G.; Leocani, L.; Onofrj, M. In: Handbook of Clinical Neurophysiology. Gastone, G.C., Ed.; Elsevier, 2005, 5, pp. 491-516.
2. van den Elsen, P.J.; van Eggermond, M.C.J.A.; Puentes, F.; van der Valk, P.; Baker, D.; Amor, S. The epigenetics of multiple sclerosis and other related disorders. Mult. Scler. Relat. Disord., 2014, 3(2), 163-175.
3. Torres-Torres, R.; Sanchez-Dalmau, B.F. Treatment of acute optic neuritis and vision complaints in multiple sclerosis. Curr. Treat. Opt. Neurol., 2015, 17(1), 328-336.
4. society, N.M. Types of MS. Accessed December 14, 2014, Available at: http://www.nationalmssociety.org/What-is-MS/ Types-of-MS.
5. Czepiel, M.; Boddeke, E.; Copray, S. Human oligodendrocytes in remyelination research. Glia, 2014, 63(4), 513-530.
6. Comerford, K.B. Recent developments in multivitamin/mineral research. Adv. Nutr., 2013, 4(6), 644-656.
7. Mikkelsen, K.; Stojanovska, L.; Apostolopoulos, V. The effects of vitamin B in depression. Curr. Med. Chem., 2016, 23(38), 4317-4337.
8. Mikkelsen, K.; Stojanovska, L.; Prakash, M.; Apostolopoulos, V. The effects of vitamin B on the immune/cytokine network and their involvement in depression. Maturitas, 2017, 96, 58-71.
9. Mikkelsen, K.; Stojanovska, L.; Tangalakis, K.; Bosevski, M.; Apostolopoulos, V. Cognitive decline: A vitamin B perspective. Maturitas, 2016, 93,108-113.
10. Dauncey, M.J. Genomic and epigenomic insights into nutrition and brain disorders. Nutrients, 2013, 5(3), 887-914.
11. Herbison, C.E.; Hickling, S.; Allen, K.L.; O’Sullivan, T.A.; Robinson, M.; Bremner, A.P.; Huang, R.C.; Beilin, L.J.; Mori, T.A.; Oddy, W.H. Low intake of B-vitamins is associated with poor adolescent mental health and behaviour. Prevent. Med., 2012, 55(6), 634-638.
12. Tucker, K.L.; Qiao, N.; Scott, T.; Rosenberg, I.; Spiro, A. 3rd, High homocysteine and low B vitamins predict cognitive decline in aging men: The veterans affairs normative aging study. Am. J. Clin. Nutr., 2005, 82(3), 627-635.
13. Donati, D.; Jacobson, S. In Polymicrobial Disease. Brogden KA, G.J., Ed.; Washington DC: ASM Press, 2002, Ch. 6, 1-49.
14. Loma, I.; Heyman, R. Multiple sclerosis: Pathogenesis and treatment. Curr. Neuropharmacol., 2011, 9(3), 409-416.
15. Simpson, S., Jr.; Blizzard, L.; Otahal, P.; Van der Mei, I.; Taylor, B. Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis. J. Neurol. Neurosurg. Psychiatr., 2011, 82(10), 1132-1141.
16. Simpson, S., Jr.; Taylor, B.; Blizzard, L.; Ponsonby, A.L.; Pittas, F.; Tremlett, H.; Dwyer, T.; Gies, P.; van der Mei, I. Higher 25- hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann. Neurol., 2010, 68(2), 193-203.
17. Trojano, M.; Lucchese, G.; Graziano, G.; Taylor, B.V.; Simpson, S., Jr.; Lepore, V.; Grand’maison, F.; Duquette, P.; Izquierdo, G.; Grammond, P.; Amato, M.P.; Bergamaschi, R.; Giuliani, G.; Boz, C.; Hupperts, R.; Van Pesch, V.; Lechner-Scott, J.; Cristiano, E.; Fiol, M.; Oreja-Guevara, C.; Saladino, M.L.; Verheul, F.; Slee, M.; Paolicelli, D.; Tortorella, C.; D’Onghia, M.; Iaffaldano, P.; Direnzo, V.; Butzkueven, H.; MSBase study group and the New Zealand, M.S.P.S.G. Geographical variations in sex ratio trends over time in multiple sclerosis. PloS One, 2012, 7(10), e48078.
18. Wu, G.F.; Alvarez, E. The immunopathophysiology of multiple sclerosis. Neurol. Clinics, 2011, 29(2), 257-278.
19. Bhatt, A.; Fan, L.W.; Pang, Y. Strategies for myelin regeneration:Lessons learned from development. Neural Regen. Res., 2014, 9(14), 1347-1350.
20. Mikkelsen, K.; Hallam, K.; Stojanovska, L.; Apostolopoulos, V. Yeast based spreads improve anxiety and stress. J. Funct. Foods, 2018, 40, 471-476.
21. Costantini, A.; Nappo, A.; Pala, M.I.; Zappone, A. High dose thiamine improves fatigue in multiple sclerosis. BMJ Ccase Rep., 2013, 2013, pii: bcr2013009144.
22. Jhala, S.S.; Hazell, A.S. Modeling neurodegenerative disease pathophysiology in thiamine deficiency: Consequences of impaired oxidative metabolism. Neurochem. Int., 2011, 58(3), 248-260.
23. Ji, Z.; Fan, Z.; Zhang, Y.; Yu, R.; Yang, H.; Zhou, C.; Luo, J.; Ke, Z.J. Thiamine deficiency promotes T cell infiltration in experimental autoimmune encephalomyelitis: The involvement of CCL2. J. Immunol., 2014, 193(5), 2157-2167.
24. van Horssen, J.; Schreibelt, G.; Drexhage, J.; Hazes, T.; Dijkstra, C.D.; van der Valk, P.; de Vries, H.E. Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radic. Biol. Med., 2008, 45(12), 1729-1737.
25. Ghadirian, P.; Jain, M.; Ducic, S.; Shatenstein, B.; Morisset, R. Nutritional factors in the aetiology of multiple sclerosis: A casecontrol study in Montreal, Canada. Int. J. Epidemiol., 1998, 27(5), 845-852.
26. Naghashpour, M.; Majdinasab, N.; Shakerinejad, G.; Kouchak, M.; Haghighizadeh, M.H.; Jarvandi, F.; Hajinajaf, S. Riboflavin supplementation to patients with multiple sclerosis does not improve disability status nor is riboflavin supplementation correlated to homocysteine. Int. J. Vitam. Nutr. Res., 2013, 83(5), 281-290.
27. Naghashpour, M.; Amani, R.; Sarkaki, A.; Ghadiri, A.; Samarbafzadeh, A.; Jafarirad, S.; Malehi, A.S. Brain-derived neurotrophic and immunologic factors: Beneficial effects of riboflavin on motor disability in murine model of multiple sclerosis. Iran. J. Basic Med. Sci., 2016, 19(4), 439-448.
28. Majewski, M.; Lebiedzinska, A. Variations of niacin content in saltwater fish and their relation with dietary RDA in Polish subjects grouped by age. Rocz. Panstw. Zakl. Hig., 2014, 65(2), 101-105.
29. Frederick, F.R. Response of peripheral and central nerve pathology to mega-doses of the vitamin B-complex and other metabolites. J. Appl. Nutr., 1973, 25, 16.
30. Komatsu, F.; Kagawa, Y.; Kawabata, T.; Kaneko, Y.; Kudoh, H.; Purvee, B.; Otgon, J.; Chimedregzen, U. Influence of essential trace minerals and micronutrient insufficiencies on harmful metal overload in a Mongolian patient with multiple sclerosis. Curr. Aging Sci., 2012, 5(2), 112-125.
31. Kaneko, S.; Wang, J.; Kaneko, M.; Yiu, G.; Hurrell, J.M.; Chitnis, T.; Khoury, S.J.; He, Z. Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models. J. Neurosci., 2006, 26(38), 9794-9804.
32. Chevalier, A.C.; Rosenberger, T.A. Increasing acetyl-CoA metabolism attenuates injury and alters spinal cord lipid content in mice subjected to experimental autoimmune encephalomyelitis. J. Neurochem., 2017, 141(5), 721-737.
33. Inglese, M.; Li, B.S.; Rusinek, H.; Babb, J.S.; Grossman, R.I.; Gonen, O. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis. Magn. Rresonan. Med., 2003, 50(1), 190-195.
34. Tartaglia, M.C.; Narayanan, S.; De Stefano, N.; Arnaoutelis, R.; Antel, S.B.; Francis, S.J.; Santos, A.C.; Lapierre, Y.; Arnold, D.L. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J. Neurol., 2002, 249(10), 1382-1390.
35. Skripuletz, T.; Manzel, A.; Gropengiesser, K.; Schafer, N.; Gudi, V.; Singh, V.; Salinas Tejedor, L.; Jorg, S.; Hammer, A.; Voss, E.; Vulinovic, F.; Degen, D.; Wolf, R.; Lee, D.H.; Pul, R.; Moharregh-Khiabani, D.; Baumgartner, W.; Gold, R.; Linker, R.A.; Stangel, M., Pivotal role of choline metabolites in remyelination. Brain. J. Neurol., 2015, 138(Pt 2), 398-413.
36. Skripuletz, T.; Linker, R.A.; Stangel, M. The choline pathway as a strategy to promote central nervous system (CNS) remyelination. Neural Regen. Res., 2015, 10(9), 1369-1370.
37. Franklin, R.J.; Ffrench-Constant, C. Remyelination in the CNS: From biology to therapy. Nat. Rev. Neurosci., 2008, 9(11), 839-855.
38. Silani, V.; Cova, L. Stem cell transplantation in multiple sclerosis:Safety and ethics. J. Neurol. Sci., 2008, 265(1-2), 116-121.
39. Kruer, M.C. In Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease (Fifth Edition). Pascual, R.N.R.M., Ed.; Academic Press: Boston, 2015, pp. 473-481.
40. Stankiewicz, J.; Panter, S.S.; Neema, M.; Arora, A.; Batt, C.E.; Bakshi, R. Iron in Chronic Brain Disorders: Imaging and Neurotherapeutic Implications. Neurotherapeutics, 2007, 4(3), 371-386.
41. Stephenson, E.; Nathoo, N.; Mahjoub, Y.; Dunn, J.F.; Yong, V.W. Iron in multiple sclerosis: Roles in neurodegeneration and repair. Nat. Rev. Neurol., 2014, 10(8), 459-468.
42. Hwang, I.K.; Yoo, K.-Y.; Kim, D.H.; Lee, B.-H.; Kwon, Y.-G.; Won, M.H. Time course of changes in pyridoxal 5_-phosphate (vitamin B6 active form) and its neuroprotection in experimental ischemic damage. Exp. Neurol., 2007, 206(1), 114-125.
43. Engelking, L.R. In Textbook of Veterinary Physiological Chemistry (3rd Ed.). Engelking, L.R., Ed.; Academic Press: Boston, 2015, pp. 271-275.
44. Bender, D.A. In Encyclopedia of Human Nutrition (3rd Ed.). Caballero, B., Ed.; Academic Press: Waltham, 2013, pp. 340-350.
45. Driskell, J.A. Vitamin B-6 requirements of humans. Nutr. Res., 1994, 14(2), 293-324.
46. Huang, S.C.; Wei, J.C.; Lin, P.T.; Wu, D.J.; Huang, Y.C. Plasma pyridoxal 5'-phosphate is not associated with inflammatory and immune responses after adjusting for serum albumin in patients with rheumatoid arthritis: A preliminary study. Ann. Nutr. Metab., 2012, 60(2), 83-89.
47. Rubi, B. Pyridoxal 5'-phosphate (PLP) deficiency might contribute to the onset of type I diabetes. Med. Hypoth., 2012, 78(1), 179-182.
48. Masse, P.G.; Boudreau, J.; Tranchant, C.C.; Ouellette, R.; Ericson, K.L. Type 1 diabetes impairs vitamin B(6) metabolism at an early stage of women’s adulthood. Appl. Physiol. Nutr. Metab., 2012, 37(1), 167-175.
49. Mitchell, D.A.; Schandl, E.K. Carbon monoxide, vitamin B6, and multiple sclerosis: a theory of interrelationship. Am. J. Clin. Nutr., 1973, 26(8), 890-896.
50. Anagnostouli, M.; Livaniou, E.; Nyalala, J.O.; Evangelatos, G.; Zournas, C.; Ithakissios, D.S.; Papageorgiou, C. Cerebrospinal fluid levels of biotin in various neurological disorders. Acta Neurol. Scand., 1999, 99(6), 387-392.
51. Sedel, F.; Papeix, C.; Bellanger, A.; Touitou, V.; Lebrun-Frenay, C.; Galanaud, D.; Gout, O.; Lyon-Caen, O.; Tourbah, A. High doses of biotin in chronic progressive multiple sclerosis: S pilot study. Mult. Scler. Relat. Disord., 2015, 4(2), 159-169.
52. Tourbah, A.; Lebrun-Frenay, C.; Edan, G.; Clanet, M.; Papeix, C.; Vukusic, S.; De Seze, J.; Debouverie, M.; Gout, O.; Clavelou, P.; Defer, G.; Laplaud, D.A.; Moreau, T.; Labauge, P.; Brochet, B.; Sedel, F.; Pelletier, J.; group, M.-S.S., MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study. Mult. Scler., 2016, 22(13), 1719-1731.
53. Nijst, T.Q.; Wevers, R.A.; Schoonderwaldt, H.C.; Hommes, O.R.; de Haan, A.F. Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia. J. Neurol. Neurosurg. Psychiatr., 1990, 53(11), 951-954.
54. Ramsaransing, G.S.; Fokkema, M.R.; Teelken, A.; Arutjunyan, A.V.; Koch, M.; De Keyser, J. Plasma homocysteine levels in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr., 2006, 77(2), 189-192.
55. Frequin, S.T.; Wevers, R.A.; Braam, M.; Barkhof, F.; Hommes, O.R. Decreased vitamin B12 and folate levels in cerebrospinal fluid and serum of multiple sclerosis patients after high-dose intravenous methylprednisolone. J. Neurol., 1993, 240(5), 305-308.
56. Bitarafan, S.; Harirchian, M.H.; Nafissi, S.; Sahraian, M.A.; Togha, M.; Siassi, F.; Saedisomeolia, A.; Alipour, E.; Mohammadpour, N.; Chamary, M.; Honarvar, N.M.; Saboor-Yaraghi, A.A. Dietary intake of nutrients and its correlation with fatigue in multiple sclerosis patients. Iran. J. Neurol., 2014, 13(1), 28-32.
57. Kanevskaia, S.A.; Kravets, A.S.; Slesarenko, E.V.; Shevchenko, V.I.; Tkachenko, N.V. Folic acid in the combined treatment of patients with disseminated sclerosis and chronic gastritis. Vrachebnoe Delo, 1990, 4(10), 96-97.
58. van Rensburg, S.J.; Kotze, M.J.; Hon, D.; Haug, P.; Kuyler, J.; Hendricks, M.; Botha, J.; Potocnik, F.C.; Matsha, T.; Erasmus, R.T. Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis. Metab. Brain Dis., 2006, 21(2-3), 121-137.
59. Likosky, W.H.; Fireman, B.; Elmore, R.; Eno, G.; Gale, K.; Goode, G.B.; Ikeda, K.; Laster, J.; Mosher, C.; Rozance, J., Intense immunosuppression in chronic progressive multiple sclerosis: The kaiser study. J. Neurol. Neurosurg. Psychiatr., 1991, 54(12), 1055-1060.
60. Kocer, B.; Engur, S.; Ak, F.; Yılmaz, M. Serum vitamin B12, folate, and homocysteine levels and their association with clinical and electrophysiological parameters in multiple sclerosis. J. Clin. Neurosci., 2009, 16(3), 399-403.
61. Moghaddasi, M.; Mamarabadi, M.; Mohebi, N.; Razjouyan, H.; Aghaei, M. Homocysteine, vitamin B12 and folate levels in Iranian patients with Multiple Sclerosis: A case control study. Clin. Neurol. Neurosurg., 2013, 115(9), 1802-1805.
62. Reynolds, E.H.; Linnell, J.C.; Faludy, J.E. Multiple sclerosis associated with vitamin B12 deficiency. Arch. Neurol., 1991, 48(8), 808-811.
63. Kira, J.; Tobimatsu, S.; Goto, I. Vitamin B12 metabolism and massive-dose methyl vitamin B12 therapy in Japanese patients with multiple sclerosis. Int. Med., 1994, 33(2), 82-86.
64. Najafi, M.R.; Shaygannajad, V.; Mirpourian, M.; Gholamrezaei, A. Vitamin B(12) deficiency and multiple sclerosis; Is there any association? Int. J. Prevent. Med., 2012, 3(4), 286-289.
65. Zhu, Y.; He, Z.-Y.; Liu, H.-N. Meta-analysis of the relationship between homocysteine, vitamin B12, folate, and multiple sclerosis. J. Clin. Neurosci., 2011, 18(7), 933-938.
66. Sandyk, R.; Awerbuch, G.I. Vitamin B12 and its relationship to age of onset of multiple sclerosis. Int. J. Neurosci., 1993, 71(1-4), 93-99.
67. Okada, K.; Tanaka, H.; Temporin, K.; Okamoto, M.; Kuroda, Y.; Moritomo, H.; Murase, T.; Yoshikawa, H. Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model. Exp. Neurol., 2010, 222(2), 191-203.
68. Ghemrawi, R.; Pooya, S.; Lorentz, S.; Gauchotte, G.; Arnold, C.; Gueant, J.L.; Battaglia-Hsu, S.F. Decreased vitamin B12 availability induces ER stress through impaired SIRT1-deacetylation of HSF1. Cell Death Dis., 2013, 4, e553.
69. Banerjee, R.V.; Matthews, R.G. Cobalamin-dependent methionine synthase. FASEB J., 1990, 4(5), 1450-1459.
70. Wade, D.T.; Young, C.A.; Chaudhuri, K.R.; Davidson, D.L. A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the “Cari Loder regime”) in the treatment of multiple sclerosis. J. Neurol. Neurosurg. Psychiatr., 2002, 73(3), 246-249.
71. Mastronardi, F.G.; Min, W.; Wang, H.; Winer, S.; Dosch, M.; Boggs, J.M.; Moscarello, M.A. Attenuation of experimental autoimmune encephalomyelitis and nonimmune demyelination by IFNbeta plus vitamin B12: treatment to modify notch-1/sonic hedgehog balance. J. Immunol., 2004, 172(10), 6418-6426.
72. Mastronardi, F.G.; Tsui, H.; Winer, S.; Wood, D.D.; Selvanantham, T.; Galligan, C.; Fish, E.N.; Dosch, H.M.; Moscarello, M.A. Synergy between paclitaxel plus an exogenous methyl donor in the suppression of murine demyelinating diseases. Mult. Scler., 2007, 13(5), 596-609.
73. Reynolds, E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol., 2006, 5(11), 949-960.
74. Krumholz, A.; Weiss, H.D.; Goldstein, P.J.; Harris, K.C. Evoked responses in vitamin B12 deficiency. Ann. Neurol., 1981, 9(4), 407-409.
75. Lysandropoulos, A.P.; Jaquiéry, E.; Jilek, S.; Pantaleo, G.; Schluep, M.; Du Pasquier, R.A. Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects. J. Neuroimmunol., 2011, 233(1-2), 240-244.
76. Bianca Velasco, A.; Tan, Z.S. In Omega-3 Fatty Acids in Brain and Neurological Health. Meester, R.R.W.D., Ed.; Academic Press:Boston, 2014, pp. 201-219.
77. Farooqui, A.A.; Ong, W.-Y.; Horrocks, L.A.; Chen, P.; Farooqui, T. Comparison of biochemical effects of statins and fish oil in brain:The battle of the titans. Brain Res. Rev., 2007, 56(2), 443-471.
78. Priyamvada, S.; Priyadarshini, M.; Arivarasu, N.A.; Farooq, N.; Khan, S.; Khan, S.A.; Khan, M.W.; Yusufi, A.N.K. Studies on the protective effect of dietary fish oil on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney. Prostagland. Leukot. Essent. Fatty Acids, 2008, 78(6), 369-381.
79. Green, R. In Encyclopedia of Human Nutrition (Third Edition). Caballero, B., Ed.; Academic Press: Waltham, 2013, pp. 351-356.
80. Puntambekar, P.; Basha, M.M.; Zak, I.T.; Madhavan, R. Rare sensory and autonomic disturbances associated with vitamin B12 deficiency. J. Neurol. Sci., 2009, 287(1-2), 285-287.
81. Zegers de Beyl, D.; Delecluse, F.; Verbanck, P.; Borenstein, S.; Capel, P.; Brunko, E. Somatosensory conduction in vitamin B12 deficiency. Electroencephalogr. Clin. Neurophysiol., 1988, 69(4), 313-318.
82. Harrington, A.L.; Dixon, T.M.; Ho, C.H. Vitamin B12 deficiency as a cause of delirium in a patient with spinal cord injury. Arch. Phys. Med. Rehabil., 2011, 92(11), 1917-1920.
83. Hebert, J.R.; Corboy, J.R. The association between multiple sclerosis-related fatigue and balance as a function of central sensory integration. Gait Posture, 2013, 38(1), 37-42.
84. Österberg, A.; Boivie, J. Central pain in multiple sclerosis - Sensory abnormalities. Eur. J. Pain, 2010, 14(1), 104-110.
85. Svendsen, K.B.; Jensen, T.S.; Hansen, H.J.; Bach, F.W. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain, 2005, 114(3), 473-481.
86. Singh, B.; Arora, S. Acute presentation of dizziness in vitamin B12 deficient old patient of cardiac disease: A case report. Clin. Chim. Acta, 2010, 411(23-24), 2104-2106.
87. Tornes, L.; Conway, B.; Sheremata, W. Multiple sclerosis and the cerebellum. Neurol. Clin., 2014, 32(4), 957-977.
88. Alguacil Diego, I.M.; Pedrero Hernández, C.; Molina Rueda, F.; Cano de la Cuerda, R. Effects of vibrotherapy on postural control, functionality and fatigue in multiple sclerosis patients: A randomised clinical trial. Neurología, 2012, 27(3), 143-153.
89. Pandey, S.; Kalita, J.; Misra, U.K. A sequential study of visual evoked potential in patients with vitamin B12 deficiency neurological syndrome. Clin. Neurophysiol., 2004, 115(4), 914-918.
90. Hickman, S.J.; Raoof, N.; McLean, R.J.; Gottlob, I. Vision and multiple sclerosis. Mult. Scler. Relat. Disord., 2014, 3(1), 3-16.
91. Kanekar, N.; Lee, Y.-J.; Aruin, A.S. Frequency analysis approach to study balance control in individuals with multiple sclerosis. J. Neurosci. Methods, 2014, 222(1), 91-96.
92. Schultheis, M.T.; Manning, K.; Weisser, V.; Blasco, A.; Ang, J.; Wilkinson, M.E. Vision and Driving in Multiple Sclerosis. Arch. Phys. Med. Rehabil., 2010, 91(2), 315-317.
93. Deppe, M.; Marinell, J.; Krämer, J.; Duning, T.; Ruck, T.; Simon, O.J.; Zipp, F.; Wiendl, H.; Meuth, S.G. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis. NeuroImage Clin., 2014, 6(1), 475-487.
94. Fernández-Menéndez, S.; Redondo-Robles, L.; García-Santiago, R.; García-González, M.Á.; Arés-Luque, A. Isolated deafness in multiple sclerosis patients. Am. J. Otolaryngol., 2014, 35(6), 810-813.
95. Roy, H.A.; Aziz, T.Z. Deep brain stimulation and multiple sclerosis: Therapeutic applications. Mult. Scler. Relat. Disord., 2014, 3(4), 431-439.
96. Sternberg, Z. Autonomic dysfunction: A unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D3, and Epstein-Barr virus. Autoimm. Rev., 2012, 12(2), 250-259.
97. Benbir, G.; Uysal, S.; Saltik, S.; Zeybek, C.A.; Aydin, A.; Dervent, A.; Yalcinkaya, C. Seizures during treatment of Vitamin B12 deficiency. Seizure, 2007, 16(1), 69-73.
98. Bittar, R.G.; Hyam, J.; Nandi, D.; Wang, S.; Liu, X.; Joint, C.; Bain, P.G.; Gregory, R.; Stein, J.; Aziz, T.Z. Thalamotomy versus thalamic stimulation for multiple sclerosis tremor. J. Clin. Neurosci., 2005, 12(6), 638-642.
99. Feys, P.; Helsen, W.; Buekers, M.; Ceux, T.; Heremans, E.; Nuttin, B.; Ketelaer, P.; Liu, X. The effect of changed visual feedback on intention tremor in multiple sclerosis. Neurosci. Lett., 2006, 394(1), 17-21.
100. Mandat, T.; Koziara, H.; Tutaj, M.; Rola, R.; Bonicki, W.; Nauman, P. Thalamic deep brain stimulation for tremor among multiple sclerosis patients. Neurol. Neurochirurg. Pol., 2010, 44(6), 542-545.
101. Rinker Ii, J.R.; Salter, A.R.; Cutter, G.R. Improvement of multiple sclerosis-associated tremor as a treatment effect of natalizumab. Mult. Scler. Relat. Disord., 2014, 3(4), 505-512.
102. Glaser, K.; Girschick, H.J.; Schropp, C.; Speer, C.P. Psychomotor development following early treatment of severe infantile vitamin B12 deficiency and West syndrome - Is everything fine? A case report and review of literature. Brain Dev., 2015, 37, 347-351.
103. Kurt, R.; Yilmaz, Y.; Ermis, F.; Kalayoglu Besisik, S.; Polat, N.; Elitok, A.; Oflaz, H.; Karan, M.A. Folic acid and vitamin B12 supplementation improves coronary flow reserve in elderly subjects with vitamin B12 deficiency. Arch. Med. Res., 2010, 41(5), 369-372.
104. Alfonsi, E.; Bergamaschi, R.; Cosentino, G.; Ponzio, M.; Montomoli, C.; Restivo, D.A.; Brighina, F.; Ravaglia, S.; Prunetti, P.; Bertino, G.; Benazzo, M.; Fontana, D.; Moglia, A. Electrophysiological patterns of oropharyngeal swallowing in multiple sclerosis. Clin. Neurophysiol., 2013, 124(8), 1638-1645.
105. Restivo, D.A.; Casabona, A.; Centonze, D.; Marchese-Ragona, R.; Maimone, D.; Pavone, A. Pharyngeal electrical stimulation for dysphagia associated with multiple sclerosis: A pilot study. Brain Stimul., 2013, 6(3), 418-423.
106. Loder, C.; Allawi, J.; Horrobin, D.F. Treatment of multiple sclerosis with lofepramine, l-phenylalanine and vitamin B12:mechanism of action and clinical importance: Roles of the locus coeruleus and central noradrenergic systems. Med. Hypotheses, 2002, 59(5), 594-602.
107. Chamot, E.; Kister, I.; Cutter, G.R. Bifactor structure of clinical disability in relapsing multiple sclerosis. Mult. Scler. Relat. Disord., 2014, 3(2), 176-185.
108. Frank, R.; Larimore, J. Yoga as a method of symptom management in multiple sclerosis. Front. Neurosci., 2015, 9, 133-141.
109. Mikkelsen, K.; Stojanovska, L.; Polenakovic, M.; Bosevski, M.; Apostolopoulos, V. Exercise and mental health. Maturitas, 2017, 106, 48-56.
110. Sijens, P.E.; Mostert, J.P.; Irwan, R.; Potze, J.H.; Oudkerk, M.; De Keyser, J. Impact of fluoxetine on the human brain in multiple sclerosis as quantified by proton magnetic resonance spectroscopy and diffusion tensor imaging. Psychiatr. Res. Neuroimag., 2008, 164(3), 274-282.
111. Smits, M.Y.; Minderhoud, J.M.; Boonstra, S.; Kuks, J.; Ter Stege, G. The ‘Flight of colours’ test in multiple sclerosis, retrobulbar neuritis and healthy controls. Clin. Neurol. Neurosurg., 1984, 86(2), 89-94.
112. Isoyama, R.; Baba, Y.; Harada, H.; Kawai, S.; Shimizu, Y.; Fujii, M.; Fujisawa, S.; Takihara, H.; Koshido, Y.; Sakatoku, J. Clinical experience of methylcobalamin (CH3- B12)/clomiphene citrate combined treatment in male infertility. Hinyokika Kiyo, 1986, 32(8), 1177-1183.
113. Altmäe, S.; Stavreus-Evers, A.; Ruiz, J.R.; Laanpere, M.; Syvänen, T.; Yngve, A.; Salumets, A.; Nilsson, T.K. Variations in folate pathway genes are associated with unexplained female infertility. Fertil. Steril., 2010, 94(1), 130-137.
114. Andretta, E.; Simeone, C.; Ostardo, E.; Pastorello, M.; Zuliani, C. Usefulness of sacral nerve modulation in a series of multiple sclerosis patients with bladder dysfunction. J. Neurol. Sci., 2014, 347(1-2), 257-261.
115. Patil, N.J.; Nagaratna, R.; Garner, C.; Raghuram, N.V.; Crisan, R. Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis-A prospectiveobservational case series. Complement. Therap. Med., 2012, 20(6), 424-430.
116. Yang, C.C. Bladder management in multiple sclerosis. Phys. Med. Rehabil. Clin. North Am., 2013, 24(4), 673-686.
117. Orasanu, B.; Frasure, H.; Wyman, A.; Mahajan, S.T. Sexual dysfunction in patients with multiple sclerosis. Mult. Scler. Relat. Disord., 2013, 2(2), 117-123.
118. Plassman, B.L.; Williams, J.J.W.; Burke, J.R.; Holsinger, T.; Benjamin, S. Systematic review: Factors associated with risk for and possible prevention of cognitive decline in later life. Ann. Int. Med., 2010, 153(3), 182-193.
119. Crowe, S.F.; Ross, C.K. Effect of folate deficiency and folate and B12 excess on memory functioning in young chicks. Pharmacol. Biochem. Behav., 1997, 56(2), 189-197.
120. Fafouti, M.; Paparrigopoulos, T.; Liappas, J.; Mantouvalos, V.; Typaldou, R.; Christodoulou, G. Mood disorder with mixed features due to vitamin B12 and folate deficiency. Gen. Hosp. Psychiatry, 2002, 24(2), 106-109.
121. Robins Wahlin, T.-B.; Wahlin, Å.; Winblad, B.; Bäckman, L. The influence of serum vitamin B12 and folate status on cognitive functioning in very old age. Biol. Psychol., 2001, 56(3), 247-265.
122. Shyambabu, C.; Sinha, S.; Taly, A.B.; Vijayan, J.; Kovoor, J.M.E. Serum vitamin B12 deficiency and hyperhomocystinemia: A reversible cause of acute chorea, cerebellar ataxia in an adult with cerebral ischemia. J. Neurol. Sci., 2008, 273(1-2), 152-154.
123. Triantafyllou, N.I.; Nikolaou, C.; Boufidou, F.; Angelopoulos, E.; Rentzos, M.; Kararizou, E.; Evangelopoulos, M.-E.; Vassilopoulos, D. Folate and vitamin B12 levels in levodopa-treated Parkinson’s disease patients: Their relationship to clinical manifestations, mood and cognition. Parkinson. Relat. Disord., 2008, 14(4), 321-325.
124. Benton, D. In: Lifetime Nutritional Influences on Cognition, Behaviour and Psychiatric Illness. Benton, D., Ed.; Woodhead Publishing, 2011, pp. 359-391.
125. Bottiglieri, T. Homocysteine and folate metabolism in depression. Prog. Neuro-Psychopharmacol. Biolog. Psychiatry, 2005, 29(7), 1103-1112.
126. Blundo, C.; Gerace, C.; Ricci, M. In: Diet and Nutrition in Dementia and Cognitive Decline. Preedy, C.R.M.R., Ed.; Academic Press: San Diego, 2015, pp. 649-662.
127. Iaffaldano, P.; Viterbo, R.G.; Goretti, B.; Portaccio, E.; Amato, M.P.; Trojano, M. Emotional and neutral verbal memory impairment in Multiple Sclerosis. J. Neurol. Sci., 2014, 341(1-2), 28-31.
128. Kasaei, F.; Hosseinian, M.M.; nezhad, G.G. A comparative study of personality characteristics and short-term memory of patients with multiple sclerosis and healthy individuals. Procedia- Social Behav. Sci., 2013, 84(1), 1856-1858.
129. Kollndorfer, K.; Krajnik, J.; Woitek, R.; Freiherr, J.; Prayer, D.; Schöpf, V. Altered likelihood of brain activation in attention and working memory networks in patients with multiple sclerosis: An ALE meta-analysis. Neurosci. Biobehav. Rev., 2013, 37(10, Part 2), 2699-2708.
130. Meyn, H.; Kraemer, M.; de Greiff, A.; Diehl, R.R. Activation of working memory in patients at the earliest stage of multiple sclerosis-An fMRI study. Clin. Neurol. Neurosurg., 2010, 112(6), 490-495.
131. Aparicio-Ugarriza, R.; Palacios, G.; Alder, M.; Gonzalez-Gross, M. A review of the cut-off points for the diagnosis of vitamin B12 deficiency in the general population. Clin. Chem. Lab. Med., 2014, 53(8), 1149-1159.
132. Dargahi, N.; Katsara, M.; Tselios, T.; Androutsou, M.E.; de Courten, M.; Matsoukas, J.; Apostolopoulos, V. Mutliple sclerosis: Immunopathology and treatment update. Brain Sci., 2017, 7(7), E78.